IP Library Granted Patent US 11,560,562
Granted Patent B2
US 11,560,562 · App. 15/907,163 · Granted Jan 24, 2023

Large-scale synthesis of messenger RNA

Inventors: Anusha Dias (Cambridge, MA); Daniel Crawford (Cambridge, MA); Frank DeRosa (Cambridge, MA); Jonathan Abysalh (Cambridge, MA); Michael Heartlein (Cambridge, MA)
Assignee: Translate Bio, Inc.
C12N15/1096C12N9/1247C12N15/1068C12P19/34C12Y207/07006G01N27/44778
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,560,562
App. No.
15/907,163
Granted
Jan 24, 2023
Kind
B2
Abstract

The present invention provides methods for large-scale production of a composition enriched for full-length mRNA molecules using an SP6 RNA polymerase and compositions produced using such methods and uses thereof.

Claims (18)

1. A method for large-scale production of a composition enriched for full-length mRNA molecules comprising synthesizing in vitro mRNA using a recombinant SP6 RNA polymerase having 90% identity to SEQ ID NO: 1, wherein the mRNA is synthesized in about 1 gram to 250 gram quantities in a single batch in a reaction mixture comprising NTPs at a concentration ranging from 1-10 mM each NTP, a DNA template at a concentration ranging from 0.01-0.5 mg/ml, the recombinant SP6 RNA polymerase at a concentration ranging from 0.01-0.1 mg/ml, and a salt or buffering agent, at pH 6.5-8.0, and wherein the reaction is incubated for 60-120 minutes at between 37° C.−42° C.

2. The method of claim 1 , wherein at least 80% of the synthesized mRNA molecules are full-length.

3. The method of claim 1 , wherein at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 99.5%, or 99.9% of the synthesized mRNA molecules are full-length.

4. The method of claim 1 , wherein the composition comprises less than 20%, 19%, 18%, 17%, 16%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, or 0.1% of abortive transcripts.

5. The method of claim 3 or 4 , wherein the full-length or abortive transcripts of mRNA are detected by agarose gel electrophoresis.

6. The method of claim 5 , wherein the mRNA is denatured by glyoxal before agarose gel electrophoresis (“glyoxal agarose gel electrophoresis”).

7. The method of claim 3 or 4 , wherein the full-length or abortive transcripts of mRNA are detected by capillary electrophoresis.

8. The method of claim 7 , wherein the capillary electrophoresis is coupled with a fluorescence-based detection.

9. The method of claim 7 , wherein the capillary electrophoresis is coupled with UV absorption spectroscopy detection.

10. The method of claim 1 , wherein the composition is substantially free of abortive transcripts.

11. The method of claim 1 , wherein the method further comprises a step of capping and/or tailing the synthesized mRNA.

12. The method of claim 1 , wherein the full-length mRNA molecule is at least 100 bases, 200 bases, 300 bases, 400 bases, 500 bases, 600 bases, 700 bases, 800 bases, 900 bases, 1 kb, 1.5 kb, 2 kb, 2.5 kb, 3 kb, 3.5 kb, 4 kb, 4.5 kb, or 5 kb in length.

13. The method of claim 1 , wherein the method further comprises a step of purifying synthesized mRNA to remove abortive transcripts.

14. The method of claim 1 , wherein the recombinant SP6 RNA polymerase has the amino acid sequence of SEQ ID NO: 1.

15. The method of claim 14 , wherein the recombinant SP6 RNA polymerase further comprises a tag.

16. The method of claim 1 , wherein the DNA template is sequence optimized.

17. The method of claim 1 , wherein the NTPs comprise one or more modified NTPs.

18. The method of claim 1 , wherein the mRNA is codon optimized.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2018
From: DIAS, ANUSHA; CRAWFORD, DANIEL; DEROSA, FRANK; ABYSALH, JONATHAN; HEARTLEIN, MICHAEL
To: TRANSLATE BIO MA, INC.
Reel/Frame 046242/0584 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2018
From: TRANSLATE BIO MA, INC.
To: TRANSLATE BIO, INC.
Reel/Frame 046242/0605 →
Continuity (2)
Provisional Application 62464043 · Feb 27, 2017
Related Publication 20180258423A1 · Sep 13, 2018
Cited By (1)
US 12,600,998